- Home
- ACCO vs AQST Comparison
ACCO vs AQST Comparison
Compare ACCO & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCO
- AQST
- Stock Information
- Founded
- ACCO 1893
- AQST 2004
- Country
- ACCO United States
- AQST United States
- Employees
- ACCO N/A
- AQST N/A
- Industry
- ACCO Publishing
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ACCO Consumer Discretionary
- AQST Health Care
- Exchange
- ACCO Nasdaq
- AQST Nasdaq
- Market Cap
- ACCO 356.9M
- AQST 390.4M
- IPO Year
- ACCO N/A
- AQST 2018
- Fundamental
- Price
- ACCO $4.01
- AQST $5.05
- Analyst Decision
- ACCO Buy
- AQST Strong Buy
- Analyst Count
- ACCO 1
- AQST 7
- Target Price
- ACCO $6.00
- AQST $10.29
- AVG Volume (30 Days)
- ACCO 487.9K
- AQST 2.4M
- Earning Date
- ACCO 10-30-2025
- AQST 11-03-2025
- Dividend Yield
- ACCO 7.48%
- AQST N/A
- EPS Growth
- ACCO N/A
- AQST N/A
- EPS
- ACCO 0.49
- AQST N/A
- Revenue
- ACCO $1,581,200,000.00
- AQST $44,132,000.00
- Revenue This Year
- ACCO N/A
- AQST N/A
- Revenue Next Year
- ACCO $2.11
- AQST $38.71
- P/E Ratio
- ACCO $8.19
- AQST N/A
- Revenue Growth
- ACCO N/A
- AQST N/A
- 52 Week Low
- ACCO $3.32
- AQST $2.12
- 52 Week High
- ACCO $6.44
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- ACCO 54.74
- AQST 66.65
- Support Level
- ACCO $3.93
- AQST $4.75
- Resistance Level
- ACCO $4.14
- AQST $5.60
- Average True Range (ATR)
- ACCO 0.09
- AQST 0.29
- MACD
- ACCO 0.00
- AQST 0.09
- Stochastic Oscillator
- ACCO 44.00
- AQST 70.59
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.